Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable
Author:
Publisher
Elsevier BV
Subject
Internal Medicine
Reference24 articles.
1. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy)–a phase 3, randomised, controlled, open-label trial;Ader;Lancet Infect Dis,2022
2. Dexamethasone in hospitalized patients with Covid-19;Horby;N Engl J Med,2021
3. The writing committee for the REMAP-CAP investigators. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial;JAMA,2020
4. Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial results;Pan;N Engl J Med,2021
5. Protocol for the DisCoVeRy trial–Multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults;Ader;BMJ Open,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Informed Consent in COVID-19-Research: An Ethical Analysis of Clinical Studies Performed during the Pandemic;Healthcare;2023-06-17
2. ‘Time out’—more transparency is required in ‘Just-in-time’ consent;European Journal of Internal Medicine;2023-02
3. Inaccurate description of staged consent;European Journal of Internal Medicine;2023-02
4. Informed consent process in the I-SPY COVID trial is questionable;European Journal of Internal Medicine;2023-01
5. Informed consent process in the ISPY COVID trial is ethically acceptable;European Journal of Internal Medicine;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3